canada semaglutide patent Ozempic's problem: how Novo Nordisk lost control of a blockbuster drug. 💉 Demand for GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite With semaglutide's patent expiring, generics

The anti-obesity medication (AOM) marketplace is rapidly expanding, with analysts estimating it to be worth $150 billion by 2032, fueled by the increasing demand for effective weight management (e.g., 15-25% weight loss) and metabolic health solutions

Weight loss itself affects periods more than Retatrutide directly

Strecker said 66 patients prescribed GLP-1 agonists for weight loss prior to surgery were matched for sex, age and BMI to 126 patients not prescribed GLP-1s

In the human body, L-carnitine is used to transport fatty acids into the cell's power plants (mitochondria), where they are "burned" into energy

Exploring oxidative modifications of tyrosine: an update on mechanisms of formation, advances in analysis and biological consequences